LABTLakewood-Amedex Biotherapeutics Inc.

$0.645
$0.025
(4.03%)
Today
Updated: 01:56 PM EDT
Mkt Cap$4.34M
Vol163,745.00

About

Lakewood-Amedex Biotherapeutics, Inc. engages in the development of novel antimicrobial therapies. Its anti-infective products targeted certain viral diseases like avian influenza, Epstein Barr Virus (EBV), and hepatitis B and C. The company was founded by Roderic Dale on July 11, 2006 and is headquartered in Bradenton, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5

Frequently Asked Questions

What is Market Cap of Lakewood-Amedex Biotherapeutics Inc.?
What is the 52-week high for Lakewood-Amedex Biotherapeutics Inc.?
What is the 52-week low for Lakewood-Amedex Biotherapeutics Inc.?
What is Lakewood-Amedex Biotherapeutics Inc. stock price today?
What was Lakewood-Amedex Biotherapeutics Inc. stock price yesterday?
What is the PE ratio of Lakewood-Amedex Biotherapeutics Inc.?
What is the Price-to-Book ratio of Lakewood-Amedex Biotherapeutics Inc.?
What is the 50-day moving average of Lakewood-Amedex Biotherapeutics Inc.?
How many employees does Lakewood-Amedex Biotherapeutics Inc. have?